Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1955 |
100 Clinical Results associated with Hebei Junlin Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Hebei Junlin Pharmaceutical Co. Ltd.
100 Deals associated with Hebei Junlin Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Hebei Junlin Pharmaceutical Co. Ltd.